Expected earnings - Journey Medical Corporation
Source: US Earnings Reports
Journey Medical Corporation (DERM) is expected to report $-0.07 for Q2 2025
Journey Medical Corporation
NASDAQ: DERM
DERM Trading
4.87% G/L:
$8.285 Last:
42,323 Volume:
$7.91 Open:
DERM Latest News
December 10, 2025 08:30:00 am
Journey Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi(TM) (DFD-29) on Microbial Flora of Healthy Adults in the Journal of Drugs in Dermatology
November 12, 2025 04:01:00 pm
Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
DERM Stock Data
$266,218,987
14,090,816
2.7%
16
N/A
Pharmaceuticals
Healthcare
US
Scottsdale
